Abstract:Highlights • EGFR + NSCs, as a subpopulation, secrete exosomes with a more potent ability to effectively promote neural regeneration. • EGFR + NSCs-Exos enhance neural autophagy and microtubule stability via the miR-34a-5p/HDAC6-dependent pathway. • Local delivery of EGFR + NSCs-Exos using 3D-printed hydrogel patches provides a precise, cell-free treatment strategy for SCI repair. Spinal cord injury (SCI) causes severe axon damage, usually leading to permanent paraparesis, which still lacks effective regenerative therapy. Recent studies have suggested that exosomes derived from neural stem cells (NSCs) may hold promise as attractive candidates for SCI treatment. Epidermal Growth Factor Receptor positive NSC (EGFR + NSC) is a subpopulation of endogenous NSCs, showing strong regenerative capability in central nervous system disease. In the current study, we isolated exosomes from the EGFR + NSCs (EGFR + NSCs-Exos) and discovered that local delivery of EGFR + NSCs-Exos can effectively promote neurite regrowth in the injury site of spinal cord-injured mice and improve their neurological function recovery. Using the miRNA-seq, we firstly characterized the microRNAs (miRNAs) cargo of EGFR + NSCs-Exos and identified miR-34a-5p which was highly enriched in EGFR + NSCs derived exosomes. We further interpreted that exosomal miR-34a-5p could be transferred to neurons and inhibit the HDAC6 expression by directly binding to its mRNA, contributing to microtubule stabilization and autophagy induction for aiding SCI repair. Overall, our research demonstrated a novel therapeutic approach to improving neurological functional recovery by using exosomes secreted from a subpopulation of endogenous NSCs and providing a precise cell-free treatment strategy for SCI repair. Graphical abstract In this study, we identified a subtype of NSCs, named EGFR + NSCs, and extracted their exosomes, which were superior in SCI repair. We demonstrated that EGFR + NSCs-derived exosomes could cross the blood-spinal cord barrier (BSCB) and downregulate HDAC6 in neurons by delivering exosomal miR-34a-5p. And the inhibition of HDAC6 activated the autophagy pathway and promoted microtubule stability to facilitate neurite growth. It highlights that EGFR + NSCs-derived exosomes can serve as a novel therapeutic agent for spinal cord injury (SCI) repair. Download : Download high-res image (235KB) Download : Download full-size image

Proteomics analysis of Schwann cell-derived exosomes: a novel therapeutic strategy for central nervous system injury

Comparative proteomic analysis of exosomes derived from endothelial cells and Schwann cells

Therapeutic effect of exosomes derived from Schwann cells in the repair of peripheral nerve injury

Schwann Cell-Derived Exosomal Vesicles: A Promising Therapy for the Injured Spinal Cord

Autophagy induced by Schwann cell-derived exosomes promotes recovery after spinal cord injury in rats

Endothelial cell-derived exosomes boost and maintain repair-related phenotypes of Schwann cells via miR199-5p to promote nerve regeneration

Exosome-mediated repair of spinal cord injury: a promising therapeutic strategy

Schwann Cell-Derived Exosomes Induced Axon Growth after Spinal Cord Injury by Decreasing PTP-σ Activation on CSPGs via the Rho/ROCK Pathway

Schwann cell‐derived exosomes: Janus‐faced mediators of regeneration and disease

Exosomes as promising bioactive materials in the treatment of spinal cord injury

Neural grafts containing exosomes derived from Schwann cell-like cells promote peripheral nerve regeneration in rats

Neuron-Derived Exosomes Promote the Recovery of Spinal Cord Injury by Modulating Nerve Cells in the Cellular Microenvironment of the Lesion Area

Exosomes Derived from Nerve Stem Cells Loaded with FTY720 Promote the Recovery after Spinal Cord Injury in Rats by PTEN/AKT Signal Pathway

Effect of Exosomes from Adipose-Derived Stem Cells on the Apoptosis of Schwann Cells in Peripheral Nerve Injury

Schwann Cell-Derived Exosomes Induce the Differentiation of Human Adipose-Derived Stem Cells Into Schwann Cells

Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Spinal Cord Injury

Local delivery of EGFR + NSCs-derived exosomes promotes neural regeneration post spinal cord injury via miR-34a-5p/HDAC6 pathway

Exosomes derived from CD271+CD56+ bone marrow mesenchymal stem cell subpopoulation identified by single-cell RNA sequencing promote axon regeneration after spinal cord injury

Neural Stem Cell-Derived Exosomes Protect Spinal Cord Injury by the Transfer of miR-31-5p

Platelet-rich plasma-derived exosomes promote blood-spinal cord barrier repair and attenuate neuroinflammation after spinal cord injury

Exosomes as a Promising Therapeutic Strategy for Peripheral Nerve Injury